The stock of Eli Lilly and Company LLY has declined 1.7% already this week, losing almost $14 billion of its market value.

A weight-loss drug more effective than Ozempic and Wegovy has recently been approved. Here’s how it works and how it compares ...

The government has suggested weight-loss drugs could boost the economy by helping obese people in England get back to work.But NHS experts have warned treatment services are already overstretched ...

Eli Lilly and Company (NYSE: LLY) today announced Zepbound® (tirzepatide) 2.5 mg and 5 mg single-dose vials are available ... of tirzepatide (Zepbound® and Mounjaro®) once weekly for long ...

single-dose vials of Zepbound. Fitch noted that many patients are often unaware that their insurance will cover GLP-1 medications. But she also emphasized that GLP-1 medications such as Mounjaro ...

Dosing a statin (rosuvastatin ... and the Hartford Hospital Cholesterol Management Center. Approximately 2600 charts were reviewed to identify patients receiving rosuvastatin EOD who previously ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

The latest weight loss medications, like Mounjaro, could be provided to help individuals re-enter the workforce and reduce healthcare costs, Streeting said. His proposal, outlined in an op-ed for ...

Earlier this year, the FDA issued a warning about dosing errors leading to "adverse events, some requiring hospitalization." "They're looking online to YouTube and saying, 'How do I dose this?' ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound were no longer in shortage after nearly two years.